Edwards Prima Plus Stentless Bioprosthesis: Long-term clinical and hemodynamic results
暂无分享,去创建一个
A. Fabbri | A. D'Onofrio | S. Auriemma | G. Cresce | P. Magagna | C. Piccin | A. Favaro
[1] A. Fabbri,et al. The inclusion technique reduces ischemia after stentless aortic root replacement. , 2008, The Annals of thoracic surgery.
[2] A. Cordell,et al. Coronary insufficiency after stentless aortic root replacement: risk factors and solutions. , 2007, The Annals of thoracic surgery.
[3] A. Fabbri,et al. Long-term results of aortic valve replacement with Edwards Prima Plus stentless bioprosthesis: eleven years' follow up. , 2006, The Journal of heart valve disease.
[4] Ofer Merin,et al. Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve. , 2004, The Annals of thoracic surgery.
[5] G. Luciani,et al. Stentless aortic valve replacement: current status and future trends , 2004, Expert review of cardiovascular therapy.
[6] A. Milano,et al. The Edwards Prima stentless valve: hemodynamic performance at one year. , 1999, The Annals of thoracic surgery.
[7] A. Arifi,et al. Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root. , 1998, The Journal of thoracic and cardiovascular surgery.
[8] A. Banning,et al. Time-related hemodynamic changes after aortic replacement with the freestyle stentless xenograft. , 1995, The Annals of thoracic surgery.
[9] T. David,et al. Aortic valve replacement with the Toronto SPV bioprosthesis. , 1992, The Journal of heart valve disease.
[10] G. Breithardt,et al. Aortic valve replacement with stentless xenografts. , 1992, The Journal of heart valve disease.
[11] L. Cohn,et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. , 1988, The Journal of thoracic and cardiovascular surgery.
[12] T. Grehl,et al. Long-term follow-up of viable frozen aortic homografts. A viable homograft valve bank. , 1987, The Journal of thoracic and cardiovascular surgery.
[13] T. Lehner,et al. Letter: Immunological features of Wegener's granulomatosis. , 1974, Lancet.
[14] J Langlois,et al. Clinical use of heterografts for replacement of the aortic valve. , 1968, The Journal of thoracic and cardiovascular surgery.
[15] M. O'brien,et al. Heterograft aortic-valve replacement. , 1967, Lancet.
[16] A. Carpentier,et al. HETEROLOGOUS AORTIC VALVE TRANSPLANTATION , 1965 .